ERCC2 E606Q
|
Urothelial Cancer
|
ERCC2 E606Q
|
Urothelial Cancer
|
cisplatin Sensitive: C4 – Case Studies
|
cisplatin Sensitive: C4 – Case Studies
|
ERCC2 E606Q
|
Urothelial Cancer
|
ERCC2 E606Q
|
Urothelial Cancer
|
gemcitabine Sensitive: C4 – Case Studies
|
gemcitabine Sensitive: C4 – Case Studies
|
ERCC2 E606Q
|
Urothelial Cancer
|
ERCC2 E606Q
|
Urothelial Cancer
|
carboplatin Sensitive: C4 – Case Studies
|
carboplatin Sensitive: C4 – Case Studies
|
ERCC2 E606Q
|
Bladder Cancer
|
ERCC2 E606Q
|
Bladder Cancer
|
cisplatin + gemcitabine Sensitive: C4 – Case Studies
|
cisplatin + gemcitabine Sensitive: C4 – Case Studies
|
ERCC2 E606Q
|
Bladder Cancer
|
ERCC2 E606Q
|
Bladder Cancer
|
carboplatin + gemcitabine Sensitive: C4 – Case Studies
|
carboplatin + gemcitabine Sensitive: C4 – Case Studies
|